FURNERI, Pio Maria
 Distribuzione geografica
Continente #
NA - Nord America 6.130
EU - Europa 3.570
AS - Asia 2.222
SA - Sud America 341
AF - Africa 169
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.445
Nazione #
US - Stati Uniti d'America 5.858
SG - Singapore 1.258
IT - Italia 1.204
IE - Irlanda 833
CN - Cina 801
UA - Ucraina 769
BR - Brasile 320
CA - Canada 257
RU - Federazione Russa 204
DE - Germania 116
SE - Svezia 107
CI - Costa d'Avorio 104
FR - Francia 87
GB - Regno Unito 61
IN - India 44
SN - Senegal 42
FI - Finlandia 34
VN - Vietnam 30
CH - Svizzera 23
NL - Olanda 21
AT - Austria 20
PL - Polonia 18
CZ - Repubblica Ceca 17
GR - Grecia 16
UZ - Uzbekistan 15
ES - Italia 12
TR - Turchia 12
LB - Libano 11
AR - Argentina 10
IR - Iran 10
MX - Messico 8
PK - Pakistan 7
EU - Europa 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
IQ - Iraq 5
MA - Marocco 5
RE - Reunion 5
AU - Australia 4
BE - Belgio 4
EC - Ecuador 4
HR - Croazia 4
JP - Giappone 4
KR - Corea 4
AZ - Azerbaigian 3
JO - Giordania 3
NZ - Nuova Zelanda 3
TN - Tunisia 3
VE - Venezuela 3
ZA - Sudafrica 3
BD - Bangladesh 2
BG - Bulgaria 2
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
IL - Israele 2
LU - Lussemburgo 2
NG - Nigeria 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
DJ - Gibuti 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
ME - Montenegro 1
MN - Mongolia 1
PE - Perù 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 12.445
Città #
Chandler 901
Santa Clara 876
Dublin 832
Jacksonville 717
Singapore 690
Chicago 419
Boardman 368
Nanjing 260
Catania 256
Cambridge 228
Lawrence 228
Andover 225
Toronto 210
Ashburn 180
San Mateo 148
Abidjan 104
Wilmington 103
Des Moines 101
Nanchang 79
Civitanova Marche 76
Hebei 72
Shenyang 68
Palermo 48
Council Bluffs 44
Ottawa 44
Saint Petersburg 44
Rome 43
Dakar 42
Tianjin 40
Changsha 39
Jiaxing 38
Los Angeles 37
Houston 29
Milan 28
São Paulo 27
The Dalles 27
Seattle 26
Munich 25
Messina 23
Bremen 22
Dong Ket 22
Norwalk 22
Padova 21
Washington 21
Falls Church 20
Pune 20
Jinan 19
Misterbianco 19
Vicenza 19
Helsinki 18
Hefei 17
Mascalucia 17
Moscow 17
Naples 17
Hangzhou 16
Beijing 15
Milazzo 14
Lecce 13
Zhengzhou 13
Lappeenranta 12
Liberty Lake 12
Viagrande 12
Kochi 11
Leawood 11
Rio de Janeiro 11
Ann Arbor 10
Augusta 10
Grafing 10
Kunming 10
Belpasso 9
Frankfurt am Main 9
Scicli 9
Bussero 8
Den Haag 8
Istanbul 8
Phoenix 8
Ardabil 7
Belo Horizonte 7
Brno 7
Dallas 7
Frankfurt Am Main 7
Hanoi 7
Hanover 7
Polska 7
Aci Sant'antonio 6
Amsterdam 6
Bologna 6
Bronte 6
Dearborn 6
Edinburgh 6
Fortaleza 6
London 6
Monmouth Junction 6
Porto Alegre 6
Turin 6
Bari 5
Capua 5
Duque de Caxias 5
Florence 5
Fuzhou 5
Totale 8.422
Nome #
Antiviral activity of clofoctol in vitro [ATTIVITA ANTIVIRALE 'IN VITRO' DELL'OCTOFENE] 133
Biological properties of Cakile maritima Scop. (Brassicaceae) extracts 129
Biological properties and production of bacteriocins-like-inhibitory substances by Lactobacillus spp. strains from human vagina 110
Antibiotic susceptibility of respiratory pathogens recently isolated in Italy 109
ANALISI DELLA SEQUENZA DELLE REGIONI A MONTE DEI "PEPTIDE SEGNALE" E "RIBOSOMAL BINDING SEQUENCE" DEI GENI ERM(B) ED ERM(A) 108
Antimicrobial and anti-proliferative effects of skin mucus derived from dasyatis pastinaca (Linnaeus, 1758) 106
Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research 106
Effects on adhesiveness and hydrophobicity of sub-inhibitory concentrations of netilmicin 100
Biological properties of itraconazole-SLN 100
Antimicrobial activity of nifuratel [ATTIVITA ANTIMICROBICA DEL NIFURATEL] 95
Dual-drugs delivery in solid lipid nanoparticles for the treatment of Candida albicans mycosis 95
SOLID LIPID NANOPARTICLES AS A STRATEGY TO IMPROVE THE IN VITRO ANTIMICROBIAL ACTIVITY OF ITRACONAZOLE 90
A method for efficient loading of ciprofloxacin hydrochloride in cationic solid lipid nanoparticles: Formulation and microbiological evaluation 86
Formulation and characterization of erythromycin–loaded Solid Lipid Nanoparticles 85
Anti-Adhesion Activity of A2-type Proanthocyanidins (a Cranberry Major Component) on Uropathogenic E. coli and P. mirabilis Strains 81
Assessment of preservative efficacy of sodium N-hydroxymethylglicinate (NIG) in drug delivery formulations for ophthalmic use 81
Bacterial symbionts of entomopathogenic nematodes of the genus Steinernema from South Italy: phenotypic features and evolutionary implications 80
Author Correction: Cytotoxicity, mutagenicity and genotoxicity of electronic cigarettes emission aerosols compared to cigarette smoke: the REPLICA project (vol 13, 17859 , 2023) 79
Il Microbiota vaginale e le infezioni urogenitali 77
Role of heme oxygenase-1 (HSP32) and HSP90 in glioblastoma 77
Influenza dell’associazione clotrimazolo/metronidazolo (1:5) sullo “switching” fenotipico di C. albicans 76
The Antimicrobial Activity of Essential Oils Against Multi-Drug-Resistance Microorganisms: A Review 76
Bacteriocins, a natural weapon against bacterial contamination for greater safety and preservation of food: a review 76
Commentary: Inflammatory and oxidative responses induced by exposure to commonly used e-cigarette flavoring chemicals and flavored e-liquids without nicotine 75
Investigation on the antibacterial activity of electronic cigarette liquids (ECLs): a proof of concept study 75
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 74
ANTI-MYCOPLASMAL ACTIVITY OF A NEW MACROLIDE - MIOCAMYCIN 74
Amensalistic Activity of Human Lactobacillus Strains Isolates 74
"Dual-drug delivery in Solid Lipid Nanoparticles: preliminary studies" 74
GenBank AF422141: Mycoplasma fermentans "incognitus strain" 23S rRNA gene, partial sequence of domain 1 73
Postbiotic Characterization in the Amensalistic Symbiosis and Correlation to the Resilience of Human Microbiota 73
Evaluation of resistance to low pH and bile salts of human Lactobacillus spp. isolates 72
Antioxidant and antimicrobial properties of Casteanea sativa Miller chestnut honey produced on Mount Etna (Sicily) 72
Analysis and sequencing of the attenuator region of erm(A) gene in Streptococcus pyogenes strains with constitutive or inducible phenotype 70
Electronic cigarette vapour enhances pneumococcal adherence to airway epithelial cells under abnormal conditions of exposure 70
Biological properties of itraconazole-SLNs 70
Metabolic Characterization of Supernatants Produced by Lactobacillus spp. With in vitro Anti-Legionella Activity 70
Pefloxacin mesilate and Ofloxacin-loaded polyethylcyanoacrylate nanoparticles. Characterization of the colloidal drug carrier formulation 69
Biofilm Formation by Streptococcus agalactiae Human Isolated Strains 69
A sustainable porous composite material based on loofah-halloysite for gas adsorption and drug delivery 67
The impact of Prulifloxacin on vaginal lactobacillus microflora:an in vivo study 66
C. Trachomatis detection in infertile women by using a tubal cytobrush during laparoscopy 66
Vaginal bacterial colonisation in post menopause: focus on uropathogenes 66
Econazole-polycarbophil, a new delivery system for topical therapy: microbiological and clinical results on vaginal candidiasis 65
GenBank AF131073: Mycoplasma hominis strain CT-PAF 23S ribosomal RNA gene, partial sequence 65
Antimicrobial nonapeptide leucinostatin A-dependent effects on the physical properties of phospholipid model membranes 64
EPIDEMIOLOGIC SURVEY OF MYCOPLASMA-PNEUMONIAE INFECTIONS - COMPARISON BETWEEN ELISA AND OTHER SEROLOGICAL TESTS 64
Two new point mutations at A2062 associated with resistance to 16-membered macrolide antibiotics in mutant strains of Mycoplasma hominis 63
Growth and adhesion to HT-29 cells inhibition of gram-negatives by Bifidobacterium longum BB536 e Lactobacillus rhamnosus HN001 alone and in combination 63
SOME PHARMACOKINETIC DATA ON MIOCAMYCIN .1. SERUM, URINARY AND PROSTATIC LEVELS 63
Analysis and Sequencing of the Regulatory Region of erm(B) in Streptococcus pyogenes Strains with “Peculiar” Inducible Phenotypes 63
New anti sars-cov-2 targets for quinoline derivatives chloroquine and hydroxychloroquine 63
Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions 62
In vitro evaluation of the synergistic activity of neomycin-polymyxin B association against pathogens responsible for otitis externa 62
Inhibitory effect of Melaleuca alternifolia (tea tree oil) on influenza A/PR/8 virus replication 62
Commentary: Lactobacilli dominance and vaginal pH: Why is the human vaginal microbiome unique? 62
Multicenter study on clinical-microbiological activity of ofloxacin in "community acquired" gynaecological infections. 62
Amphiphilic ion pairs of tobramycin with lipoamino acids 62
Amphiphilic erythromycin-lipoamino acid ion-pairs: characterization and in vitro microbiological evaluation 62
Assenza di penicillino resistenza in ceppi di Streptococcus agalactiae isolati in Sicilia 62
In vitro antimycoplasmal activity of Melaleuca alternifolia essential oil 61
Management of Aerobic Vaginitis 61
SOME PHARMACOKINETIC DATA ON MIOCAMYCIN .2. CONCENTRATIONS IN GYNECOLOGICAL TISSUES 61
Evaluation of antinfective activity of an association bifidobacterium/lactobacillus in mouse intestine 61
Anti-mycoplasmal activity of hydroxytyrosol 61
Lipid Nanoparticles and Active Natural Compounds: A Perfect Combination for Pharmaceutical Applications 61
Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43 60
Effects of Mangiferin on LPS-Induced Inflammation and SARS-CoV-2 Viral Adsorption in Human Lung Cells 60
Intracellular accumulation of ofloxacin-loaded liposmes in human synovial fibroblasts 60
Nanosized devices as antibiotics and antifungals delivery: past, news, and outlook 60
Caratterizzazione molecolare di ceppi di Lactobacillus spp. utilizzati in prodotti probiotici vaginali e determinazione della sensibilità agli antibiotici 60
Analisi retrospettiva sulla sensibilità in vitro agli antibiotici del gruppo MLS in Streptococcus agalactiae daal 1994 al 2005 60
Combining molecular modeling with experimental methodologies: mechanism of membrane permeation and accumulation of ofloxacin 60
Nuove tecniche di analisi molecolare per l'identificazione delle comunità microbiche vaginali 59
In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis 59
Solid Dispersions of Chitosan Glutamate for the Local Delivery of Miconazole: Characterization and In Vitro Activity 59
In vitro Antimycoplasmal Activity of Citrus bergamia Essential Oil and its Derivatives 59
Probiotic Properties of Lactobacillus fermentum Strains Isolated from Human Oral Samples and Description of their Antibacterial Activity 59
Laparoscopy diagnosis of chlamydial salpingitis using a tubal cytobrush 59
Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological Aspects 59
Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS-CoV-2 58
Correlation between PRTF1-F2 and macrolide resistance in Streptococcus pyogenes 58
Colistin and Kanamycin Together in Association with Coridothymus capitatus to Enhance their Antimicrobial Activity and Fight Multidrug-Resistance Pathogens 58
In vitro antimycoplasmal activity of citrus bergamia essential oil and its major components 57
Analisi e sequenziamento della regione regolatrice del gene erm(A) ad espressione costitutiva o inducibile 57
SEQUENZIAMENTO DEL GENOMA DI MYCOPLASMA HOMINIS: I. STRATEGIE PER IL CLONAGGIO E CREAZIONE DELLA BANCA COSMIDICA 57
GenBank EU492925: Streptococcus pyogenes strain 3-CT leader peptide 1 (lpg1) and leader peptide 2 lpg2) genes, complete cds; and erythromycin resistance methylase [erm(A)] gene, partial cds, 57
GenBank AF317663: Mycoplasma hominis strain PG21/JR2 23S ribosomal RNA gene, partial sequence 57
Longitudinal study on the therapy of Mycoplasma pneumoniae infections with ciprofloxacin on Syrian hamsters 57
Biofilm Formation by Streptococcus agalactiae Human Isolated Strains 56
ISOLAMENTO E CARATTERIZZAZIONE DI STREPTOCOCCUS AGALACTIAE IN DONNE GRAVIDE 55
Spiroplasma spp.: A Plant, Arthropod, Animal and Human Pathogen 55
VI-5. Dosaggio microbiologico degli antibiotici 55
Correlation Between Virulence Factors and Macrolide Resistance in Streptococcus pyogenes 55
INFEZIONI BATTERICHE CRONICO-DEGENERATIVE: I MICOPLASMI 55
Lactobacillus rhamnosus AD3 as a promising alternative for probiotic products 55
Preparation and Microbiological Evaluation of Amphiphilic Kanamycin-Lipoamino Acid Ion-Pairs 54
Solid dispersions of chitosan glutamate for local delivery of miconazole 54
Relationships between hydrophobicity and biofilm formation in Streptococcus agalactiae strains 54
Sequenziamento del gene per la 23 S ribosomiale di Mycoplasma fermentans group ed identificazione di domini correlati con l’antibiotico resistenza 54
Totale 6.960
Categoria #
all - tutte 47.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020216 0 0 0 0 0 0 0 0 0 0 162 54
2020/20211.462 41 154 165 111 409 47 122 16 114 4 193 86
2021/20221.751 212 271 12 38 266 21 247 59 176 11 76 362
2022/20232.691 244 109 42 258 287 503 15 401 652 38 96 46
2023/20241.109 90 140 56 66 55 210 9 55 15 27 233 153
2024/20253.907 51 849 288 209 869 373 159 244 326 480 59 0
Totale 12.839